Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
Sales rise 6.56% to Rs 23.56 crore
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales23.5622.11 7 OPM %23.4719.13 -PBDT5.173.94 31 PBT5.013.75 34 NP5.053.68 37Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 11 2025 | 3:30 PM IST